Part 4/6:
In contrast, synthetic drugs like fentanyl pose a different challenge. Their small size, high potency, and the ease of manufacturing in clandestine labs mean that enforcement efforts are less effective. The sheer volume of small shipments floating through the supply chain makes it nearly impossible to stop every delivery.
Rethinking Strategies: Beyond Supply-Side Solutions
Given these realities, the speaker advocates for a paradigm shift in tackling the synthetic drug epidemic. Focusing solely on supply-side measures is insufficient. Instead, a comprehensive approach that also emphasizes demand reduction, treatment, and harm reduction strategies is essential.